GW&K Investment Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23K Sell
104
-6
-5% -$1.5K ﹤0.01% 734
2025
Q4
$26K Buy
110
+4
+4% +$1.02K ﹤0.01% 692
2025
Q3
$29K Hold
106
﹤0.01% 649
2025
Q2
$27K Buy
106
+2
+2% +$477 ﹤0.01% 636
2025
Q1
$23K Hold
104
﹤0.01% 624
2024
Q4
$24K Buy
104
+2
+2% +$482 ﹤0.01% 586
2024
Q3
$25K Buy
102
+19
+23% +$4.25K ﹤0.01% 573
2024
Q2
$16K Buy
83
+7
+9% +$1.42K ﹤0.01% 612
2024
Q1
$15K Buy
76
+2
+3% +$366 ﹤0.01% 590
2023
Q4
$13K Buy
74
+30
+68% +$4.61K ﹤0.01% 612
2023
Q3
$7K Buy
44
+2
+5% +$362 ﹤0.01% 727
2023
Q2
$9K Buy
+42
New +$9.36K ﹤0.01% 645
2022
Q3
Sell
-17
Closed -$4K 743
2022
Q2
$4K Buy
17
+8
+89% +$1.7K ﹤0.01% 651
2022
Q1
$2K Buy
+9
New +$2.18K ﹤0.01% 723
2014
Q4
Sell
-60,359
Closed -$2.97M 222
2014
Q3
$2.97M Sell
60,359
-27,929
-32% -$1.42M 0.08% 174
2014
Q2
$4.47M Buy
88,288
+8,038
+10% +$398K 0.11% 163
2014
Q1
$3.59M Buy
80,250
+6,847
+9% +$308K 0.1% 164
2013
Q4
$3.46M Buy
73,403
+9,377
+15% +$475K 0.09% 154
2013
Q3
$3.38M Buy
64,026
+2,630
+4% +$128K 0.1% 151
2013
Q2
$2.77M Buy
+61,396
New +$2.91M 0.1% 151

Other funds holding RMD

GW&K Investment Management's RMD Position: Q1 2026 in Review

GW&K Investment Management reduced its ResMed (RMD) stake by 5.5% in Q1 2026, selling an estimated $1.5K and leaving 104 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #734.

GW&K Investment Management first reported a position in RMD in Q2 2013 and has held it in 20 quarters since. The position peaked at $4.47M in Q2 2014. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • GW&K Investment Management held 104 shares of ResMed worth $23K as of Q1 2026.
  • GW&K Investment Management sold 6 ResMed shares in Q1 2026, an estimated $1.5K.
  • ResMed made up ﹤0.01% of GW&K Investment Management's portfolio in Q1 2026, its #734 holding.
  • GW&K Investment Management first reported a position in ResMed in Q2 2013 and has held it in 20 quarters since.
  • GW&K Investment Management's ResMed position peaked at $4.47M in Q2 2014.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on GW&K Investment Management's 13F filing for Q1 2026, filed 13 May 2026.